Key Events This Week
8 June: Stock opens at Rs.1,005.20, down 3.62% amid broad market weakness
11 June: Valuation shifts to very attractive despite price dip to Rs.977.95
12 June: Intraday high of Rs.1,062.90 with a 7.14% surge closing at Rs.1,054.30
12 June: Week closes at Rs.1,054.30, up 1.09% for the week versus Sensex +0.57%

Strides Pharma Science Ltd Surges 7.14% to Day's High of Rs 1062.9 — Outperforms Sector by 6.32 Percentage Points
2026-06-12 15:33:21The Sensex climbed 2.3% on 12 Jun 2026, yet Strides Pharma Science Ltd outpaced the broader market with a 7.14% gain, reaching an intraday high of Rs 1062.9. This 6.32 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a mere market tailwind.
Read full news article
Strides Pharma Science Ltd is Rated Hold
2026-06-12 10:10:05Strides Pharma Science Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 06 April 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 12 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Strides Pharma Science Ltd Valuation Shifts to Very Attractive Amid Market Volatility
2026-06-11 08:00:53Strides Pharma Science Ltd has seen a marked improvement in its valuation metrics, shifting from an attractive to a very attractive rating, even as the broader pharmaceuticals sector faces headwinds. With a current price-to-earnings (P/E) ratio of 15.56 and a price-to-book value (P/BV) of 2.90, the company stands out favourably against its peers, signalling a potential opportunity for investors seeking value in a challenging market environment.
Read full news article
Strides Pharma Science Ltd Technical Momentum Shifts Signal Bullish Outlook
2026-06-03 08:03:32Strides Pharma Science Ltd has recently exhibited a notable shift in its technical momentum, upgrading from a mildly bullish to a bullish trend. Despite a day’s decline of 1.73%, the stock’s technical indicators reveal a complex interplay of bullish and bearish signals, suggesting a nuanced outlook for investors in this small-cap pharmaceutical player.
Read full news article
Strides Pharma Science Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-06-02 08:05:53Strides Pharma Science Ltd has experienced a nuanced shift in its technical momentum, transitioning from a bullish to a mildly bullish trend as of early June 2026. While key weekly and monthly indicators such as MACD remain positive, bearish signals from RSI and mixed readings from other oscillators suggest a complex near-term outlook for this small-cap pharmaceutical player.
Read full news article
Strides Pharma Science Ltd is Rated Hold
2026-06-01 10:10:04Strides Pharma Science Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 06 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.
Read full news articleStrides Pharma Science Ltd’s Volatile Week: -0.08% Price Change Amid Mixed Signals
2026-05-23 16:05:20
Key Events This Week
18 May: Q4 FY26 results reveal strong profit growth amid margin concerns
19 May: Intraday low hit at Rs.1,045.8 amid heavy price pressure despite positive market
19 May: Positive quarterly performance reported with 27.1% PAT growth
22 May: Week closes at Rs.1,153.05, down 0.08% for the week

Strides Pharma Science Ltd is Rated Hold
2026-05-21 10:10:05Strides Pharma Science Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 06 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news articleAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
08-Jun-2026 | Source : BSEIntimation of Schedule of Analyst/ Institutional Investors Meet
Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Reminder To Shareholders Regarding Unclaimed Dividends And Transfer To IEPF
01-Jun-2026 | Source : BSEReminder to Shareholders regarding Unclaimed Dividends and Transfer to IEPF
Intimation Of Effective Date For The Scheme Of Demerger Involving Arco Lab Private Limited (Arco Lab) And Pivot Path Private Limited (Pivot Path)
01-Jun-2026 | Source : BSEIntimation of Effective Date for Scheme of Demerger involving Arco Lab Private Limited (Arco Lab) and (Pivot Path Private Limited).
Corporate Actions
No Upcoming Board Meetings
Strides Pharma Science Ltd has declared 40% dividend, ex-date: 22 Jul 25
No Splits history available
No Bonus history available
No Rights history available






